Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ASDSA Recognizes 2024 Patient Safety Hero Award Honorees
-
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
-
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
-
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
-
Revolutionizing Lighting: Superior LED Technologies Unveils Industry's Most Efficient Lights, Setting a New Standard
-
Mesa Air Group Reports Third Quarter Fiscal 2024 Results
-
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
-
Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
-
Hydreight Provides Corporate Update Reflecting Significant Growth
-
Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
-
Barrick Reports Q3 Preliminary Production Results With Continued Improvement at Pueblo Viejo
-
Apellis Announces Oral Presentation at American Society of Nephrology (ASN) Kidney Week on Phase 3 VALIANT Study of Pegcetacoplan in C3G and Primary IC-MPGN
-
Tilray Announces Fall Craft Beer Lineup
-
New York Supreme Court Rules in Favor of Gyrodyne in Article 78 Proceeding
-
Revving Vive’s Highest Velocity Commercialization Engine
-
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
-
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
-
ICPO Foundation funded global “Radiopharmaceutical Trial Finder” developed by WARMTH and Ancora.ai
-
Green Ammo Secures Contracts with U.S. Department of Defense to Deliver Nearly 1,300 E-Blanks Training Kits Amid Global Blank Ammunition Shortage
-
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
-
YieldMax™ ETFs Announces Distributions on FIAT (105.76%), CONY (101.35%), ULTY (100.99%), YMAX (51.97%), YMAG (62.33%) and Others
-
Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings
-
Cathay Cargo Leveraged Descartes Air Cargo Tracking Solution to Help Support Safe Journey of Giant Pandas
-
Kraken Robotics Receives $13 Million of Subsea Battery Orders
-
Nova Minerals Drills 39m @ 5.4 g/t Au from Surface at the RPM Deposit on its Estelle Gold-Antimony Project, in Alaska
-
Taboola to Release Third Quarter 2024 Financial Results and Host Earnings Conference Call on November 7, 2024
-
Nanjing Medical University Celebrates 90th Anniversary
-
Chinese Anime IP Ignites Cultural and Tourism Consumption Vitality in Qianhai, Shenzhen
-
Verisk Estimates Industry Insured Losses for Hurricane Milton Will Range Between USD 30 Billion to USD 50 Billion
-
2024 Jingfang International Conference: Shared Utilization Worldwide
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Food Basics is celebrating Diwali by shining an even brighter light on the occasion
-
Gilat Satellite Networks to Present at the 17th Annual LD Micro Invitational Conference
-
Arctic Wolf 2024 Human Risk Behavior Snapshot Reveals Nearly Two-Thirds of Security and IT Leaders Have Fallen for Phishing Attacks
-
Clean energy technologies save households serious money, but the barrier to entry increased in 2024: report
-
MADD Canada Brings New School Program to Newfoundland and Labrador Students
-
Suspected Digital Fraud Coming from Canada Up Nearly 11% Since H1 2023, Reveals New TransUnion Analysis
-
VedTechBio® Launches RxAgentAI™ – an Artificial Intelligence and Machine Learning Platform, catering to the decision making and strategic needs of stakeholders in the life sciences industry AND V
-
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
-
LanzaTech Awarded $3 Million from U.S. Department of Energy to Advance Conversion of Waste CO2 into Valuable Chemicals
-
Parsons Awarded $25M Contracts for Middle East Transportation Projects
-
Medallion Financial Corp. to Report 2024 Third Quarter Results on Tuesday, October 29, 2024
-
Norsk Hydro: Status share buyback program
-
MT Højgaard Holding: Financial calender 2025
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
-
Neurogastrx Announces Positive Proof-of-Concept Data for Investigational Drug NG101 in Reducing Nausea and Vomiting Associated with the Administration of GLP-1 Agonist Medication
-
Net Asset Value(s)
-
Medigene to Present at Upcoming Scientific Conferences
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Man Group PLC : Form 8.3 - Centamin plc

